A progressive disease of the nervous system marked by tremor, muscular rigidity, and slow, imprecise movement, chiefly affecting middle-aged and elderly people. It is associated with degeneration of the basal ganglia of the brain and a deficiency of the neurotransmitter dopamine.
On the “Living with Parkinson’s” pages of the Michael J. Fox Foundation for Parkinson’s Research Web site, information about the disease is offered for patients and caregivers, and links to additional resources are provided.
The National Parkinson Foundation site provides news and information about events, conferences, and symposia, and a range of electronic and print information (some in Spanish) helpful to Parkinson's patients and care givers.
The Parkinson's Disease Foundation's Web site includes an overview of the disease's symptoms and treatments and strategies for living with Parkinson’s Disease. An "ask the expert" feature is available for specific questions.
Parkinson's Disease: Hope Through Research is a comprehensive booklet, available on-line from the National Institute of Neurological Disorders and Stroke (a member of the U.S. government National Institutes of Health), covering topics from the symptoms of Parkinson's to treatment, diet, exercise, promising research, and resources for further information.
Findings also hint that “synucleinopathies” may
in rare cases be contagious.
Stimulating the brain with electricity has been used for many years to treat various brain disorders and researchers continue to hone its capabilities.
Stem Cell Transplants Show Promise for Future Parkinson’s Treatments
Parkinson's disease is a debilitating neurodegenerative disorder that targets dopaminergic cells in an area of the brain called the substantia nigra. Most patients are treated with the drug Levodop
Gene-environment Interactions in Parkinson’s Disease
Paul Barrett, Ph.D. Department of Neurology and Pittsburgh Institute for Neurodegenerative Diseases University of Pittsburgh, School of Medicine
J. Timothy Greenamyre
Symptoms of the disease follow the deaths of motor neurons, but ALS’s ultimate cause may lie elsewhere.
Parkinson’s disease (PD) is the second most common neurodegenerative disease after Alzheimer’s, affecting approximately 5 million persons worldwide. With the population aging, it is anticipated that the number of patients with PD will increase dramatically in the coming decades.